[1]郝媛媛.富马酸比索洛尔联合曲美他嗪治疗急性冠心病心力衰竭的疗效[J].医学信息,2020,33(02):147-148.[doi:10.3969/j.issn.1006-1959.2020.02.044]
　HAO Yuan-yuan.Effect of Bisoprolol Fumarate Combined with Trimetazidine in the Treatment of Heart Failure in Patients with Acute Coronary Heart Disease[J].Medical Information,2020,33(02):147-148.[doi:10.3969/j.issn.1006-1959.2020.02.044]
点击复制

富马酸比索洛尔联合曲美他嗪治疗急性冠心病心力衰竭的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年02期
页码:
147-148
栏目:
药物与临床
出版日期:
2020-01-15

文章信息/Info

Title:
Effect of Bisoprolol Fumarate Combined with Trimetazidine in the Treatment of Heart Failure in Patients with Acute Coronary Heart Disease
文章编号:
1006-1959（2020）02-0147-02
作者:
郝媛媛
（天津市蓟州区人民医院内科，天津 301900）
Author(s):
HAO Yuan-yuan
(Department of Internal Medicine,Jizhou District People’s Hospital,Tianjin 301900,China)
关键词:
富马酸比索洛尔; 曲美他嗪; 冠心病; 心力衰竭
Keywords:
Bisoprolol fumarate; Trimetazidine; Coronary heart disease; Heart failure
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2020.02.044
文献标志码:
A
摘要:
目的 观察富马酸比索洛尔联合曲美他嗪治疗冠心病心力衰竭的疗效。方法 选择2018年2月~2019年2月我院诊治的冠心病心力衰竭患者90例，随机分为对照组和观察组，各45例。对照组在常规治疗基础上采用富马酸比索洛尔治疗，观察组在对照组基础上联合曲美他嗪治疗，比较两组临床治疗总有效率、左心室射血分数（LVEF）、心率（HR）、左心室收缩末容积指数（LVESVI）、E峰血流速率（E峰）、晚期充盈A峰速率（A峰）、E/A、左房内径（LAD）。结果 观察组治疗总有效率（95.56%）高于对照组（82.22%）（P＜0.05）；两组LVEF、HR、LVESVI、E峰、A峰、E/A、LAD均较治疗前改善，且观察组优于对照组（P＜0.05）。结论 富马酸比索洛尔联合曲美他嗪治疗冠心病心力衰竭疗效确切，可促进左室心功能恢复，改善患者临床症状。
Abstract:
Objective To observe the efficacy of bisoprolol fumarate combined with trimetazidine in the treatment of coronary heart disease and heart failure. Methods 90 patients with coronary heart disease and heart failure diagnosed and treated in our hospital from February 2018 to February 2019 were randomly divided into a control group and an observation group, each with 45 patients. The control group was treated with bisoprolol fumarate on the basis of conventional treatment, and the observation group was combined with trimetazidine on the basis of the control group. The total effective rate, left ventricular ejection fraction （LVEF）, and heart rate （ HR）, left ventricular end-systolic volume index （LVESVI）, E-peak blood flow rate （E-peak）, late filling A-peak rate （A-peak）, E / A, and left atrial inner diameter （LAD）.Results The total effective rate in the observation group （95.56%） was higher than that in the control group （82.22%） （P<0.05）.The LVEF, HR, LVESVI, E-peak, A-peak, E/A, and LAD of the two groups were all improved compared with those before treatment, and the observation group was better than the control group（P<0.05）.Conclusion Bisoprolol fumarate combined with trimetazidine is effective in the treatment of coronary heart disease heart failure, which can promote the recovery of left ventricular function and improve the clinical symptoms of patients.

参考文献/References:

[1]周伟君,王明生,王仁颖,等.富马酸比索洛尔与阿替洛尔对原发性高血压患者静息心率及交感神经活性的影响[J].中华高血压杂志,2014,22(11):1061-1065. [2]顾志燕,王永.参麦联合环磷腺苷葡胺治疗冠心病心力衰竭临床观察[J].西部中医药,2014,27(11):112-114. [3]甄宇治.比索洛尔联合曲美他嗪治疗左心室射血分数保留的心力衰竭的临床研究[J].中国临床药理学杂志,2016,32(19):1735-1737. [4]阎燕,何爱萍.稳心颗粒联合富马酸比索洛尔治疗心力衰竭合并室性早搏的临床研究[J].药物评价研究,2017,40(4):537-540. [5]谢爵隆,黄晓波,杨名宇.比索洛尔与曲美他嗪治疗冠心病心力衰竭的临床分析[J].医学理论与实践,2014,27(14):1856-1858.

相似文献/References:

[1]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Medical Information,2018,31(02):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[2]王 毅.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果评价[J].医学信息,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
　WANG Yi.Clinical Evaluation of Atto Vastatin Combined with Trimetazidine in the Treatment of Coronary Atherosclerotic Heart Disease[J].Medical Information,2018,31(02):139.[doi:10.3969/j.issn.1006-1959.2018.13.041]
[3]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Medical Information,2018,31(02):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[4]岳卫东.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床研究[J].医学信息,2018,31(21):141.[doi:10.3969/j.issn.1006-1959.2018.21.040]
　YUE Wei-dong.Clinical Study of Trimetazidine Combined with Atorvastatin Calcium in the Treatment of Coronary Heart Disease Angina Pectoris with Dyslipidemia[J].Medical Information,2018,31(02):141.[doi:10.3969/j.issn.1006-1959.2018.21.040]
[5]宫慧超,王 辉,刘迎午.尼可地尔联合曲美他嗪在不稳定心绞痛患者中应用的临床研究[J].医学信息,2019,32(07):148.[doi:10.3969/j.issn.1006-1959.2019.07.045]
　GONG Hui-chao,WANG Hui,LIU Ying-wu.Clinical Study of Nicorandil Combined with Trimetazidine in Patients with Unstable Angina Pectoris[J].Medical Information,2019,32(02):148.[doi:10.3969/j.issn.1006-1959.2019.07.045]
[6]张文航.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴 血脂异常的临床疗效[J].医学信息,2019,32(18):144.[doi:10.3969/j.issn.1006-1959.2019.18.049]
　ZHANG Wen-hang.Clinical Efficacy of Trimetazidine Combined with Atorvastatin Calcium in the Treatment of Coronary Heart Disease Angina Pectoris with Dyslipidemia[J].Medical Information,2019,32(02):144.[doi:10.3969/j.issn.1006-1959.2019.18.049]
[7]纪东华.曲美他嗪治疗老年冠心病心力衰竭的疗效及其对患者 炎症因子的影响[J].医学信息,2019,32(13):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
　JI Dong-hua.Efficacy of Trimetazidine in the Treatment of Elderly Patients with Coronary Heart Disease and Its Effect on Inflammatory Factors[J].Medical Information,2019,32(02):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
[8]邓嘉奇,曾祥斌,刘 琳,等.阿托伐他汀联合曲美他嗪在冠心病治疗中的临床疗效及对预后的影响[J].医学信息,2024,37(20):96.[doi:10.3969/j.issn.1006-1959.2024.20.018]
　DENG Jiaqi,ZENG Xiangbin,LIU Lin,et al.Clinical Efficacy of Atorvastatin Combined with Trimetazidine in the Treatment of Coronary Heart Disease and its Effect on Prognosis[J].Medical Information,2024,37(02):96.[doi:10.3969/j.issn.1006-1959.2024.20.018]

更新日期/Last Update: 2020-01-15